Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 72

1.

Replication of microchannel structures in WC-Co feedstock using elastomeric replica moulds by hot embossing process.

Sahli M, Gelin JC, Barrière T.

Mater Sci Eng C Mater Biol Appl. 2015 Oct;55:252-66. doi: 10.1016/j.msec.2015.05.019. Epub 2015 May 9.

PMID:
26117760
2.

National experience with extracranial carotid artery aneurysms: epidemiology, surgical treatment strategy, and treatment outcome.

Nordanstig J, Gelin J, Jensen N, Osterberg K, Strömberg S.

Ann Vasc Surg. 2014 May;28(4):882-6. doi: 10.1016/j.avsg.2013.08.011. Epub 2013 Nov 1.

PMID:
24189193
3.

Very urgent carotid endarterectomy confers increased procedural risk.

Strömberg S, Gelin J, Osterberg T, Bergström GM, Karlström L, Osterberg K; Swedish Vascular Registry (Swedvasc) Steering Committee.

Stroke. 2012 May;43(5):1331-5. doi: 10.1161/STROKEAHA.111.639344. Epub 2012 Mar 15.

4.

Comment regarding "Rapid access carotid endarterectomy can be performed in the hyperacute period without a significant increase in procedural risks" by M.K. Salem, R.D. Sayers, M.J. Brown, D.J. Eveson, T.G. Robinson and A.R. Naylor.

Jivegård L, Gelin J, Strömberg S, Österberg K.

Eur J Vasc Endovasc Surg. 2011 Sep;42(3):403; author reply 403-4. doi: 10.1016/j.ejvs.2011.04.036. Epub 2011 May 31. No abstract available.

5.

Walking performance and health-related quality of life after surgical or endovascular invasive versus non-invasive treatment for intermittent claudication--a prospective randomised trial.

Nordanstig J, Gelin J, Hensäter M, Taft C, Österberg K, Jivegård L.

Eur J Vasc Endovasc Surg. 2011 Aug;42(2):220-7. doi: 10.1016/j.ejvs.2011.02.019. Epub 2011 Mar 11.

6.

Comment on "What is the place of surgery for intermittent claudication?".

Jivegård L, Gelin J, Nordanstig J, Österberg K, Taft C.

Eur J Vasc Endovasc Surg. 2011 Feb;41(2):294; author reply 294-5. doi: 10.1016/j.ejvs.2010.10.012. Epub 2010 Dec 3. No abstract available.

7.

10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): a multicentre randomised trial.

Halliday A, Harrison M, Hayter E, Kong X, Mansfield A, Marro J, Pan H, Peto R, Potter J, Rahimi K, Rau A, Robertson S, Streifler J, Thomas D; Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group.

Lancet. 2010 Sep 25;376(9746):1074-84. doi: 10.1016/S0140-6736(10)61197-X.

8.
9.

Effects of three months of low molecular weight heparin (dalteparin) treatment after bypass surgery for lower limb ischemia--a randomised placebo-controlled double blind multicentre trial.

Jivegård L, Drott C, Gelin J, Groth O, Hensäter M, Jensen N, Johansson G, Konrad P, Lindberg B, Lindhagen A, Lundqvist B, Oden A, Smith L, Stenberg B, Thornell E, Wingren U, Ortenwall P.

Eur J Vasc Endovasc Surg. 2005 Feb;29(2):190-8.

10.

Multicenter clinical experience with large core soft tissue biopsy without vacuum assistance.

Rotenberg L, Verhille R, Schulz-Wendtland R, Verswijfel G, Gelin J, Van Migem D, Janssens JP.

Eur J Cancer Prev. 2004 Dec;13(6):491-8.

PMID:
15548942
11.

[Thoracic and abdominal aorta aneurysms demand an experienced team work].

Risberg B, Brandrup-Wognsen G, Delle M, Gelin J, Lepore V, Lönn L, Rådberg G, Westerlind A.

Lakartidningen. 2004 May 6;101(19):1706-8, 1710-1. Review. Swedish.

PMID:
15188584
12.

Predictors of treatment outcome in intermittent claudication.

Taft C, Sullivan M, Lundholm K, Karlsson J, Gelin J, Jivegård L.

Eur J Vasc Endovasc Surg. 2004 Jan;27(1):24-32.

13.

Treatment efficacy of intermittent claudication by invasive therapy, supervised physical exercise training compared to no treatment in unselected randomised patients II: one-year results of health-related quality of life.

Taft C, Karlsson J, Gelin J, Jivegård L, Sandström R, Arfvidsson B, Dahllöf AG, Lundholm K, Sullivan M.

Eur J Vasc Endovasc Surg. 2001 Aug;22(2):114-23.

14.
15.
16.

Granulosa cell tumor of the ovary.

Volders W, Billen M, Claes P, Gelin J, Palmers Y.

J Belge Radiol. 1998 Oct;81(5):256. No abstract available.

PMID:
9880981
17.

Are cytokines possible mediators of cancer cachexia?

Noguchi Y, Yoshikawa T, Matsumoto A, Svaninger G, Gelin J.

Surg Today. 1996;26(7):467-75. Review.

PMID:
8840426
18.

Effects related to indomethacin prolonged survival and decreased tumor-growth in a mouse-tumor model with cytokine dependent cancer cachexia.

Lonnroth C, Svaninger G, Gelin J, Cahlin C, Iresjo B, Cvetkovska E, Edstrom S, Andersson M, Svanberg E, Lundholm K.

Int J Oncol. 1995 Dec;7(6):1405-13.

PMID:
21552980
19.

Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors.

Lundholm K, Gelin J, Hyltander A, Lönnroth C, Sandström R, Svaninger G, Körner U, Gülich M, Kärrefors I, Norli B, et al.

Cancer Res. 1994 Nov 1;54(21):5602-6.

20.

Expression of interleukin-6 in tumor-bearing mice with cytokine dependent cachexia.

Lonnroth C, Gelin J, Lundholm K.

Int J Oncol. 1994 Aug;5(2):329-36.

PMID:
21559593

Supplemental Content

Loading ...
Support Center